Ovarian preservation during the surgical treatment of early stage endometrial cancer: A nation-wide study conducted by the Korean Gynecologic Oncology Group

Gynecologic Oncology

Volumn 115, Issue 1, 2009, Pages 26-31

  Lee, Taek Sang ^a   Kim, Jae Weon ^b   Kim, Tae Jin ^c   Cho, Chi Heum ^d   Ryu, Sang Young ^e   Ryu, Hee Sug ^f   Kim, Byoung Gie ^g   Lee, Keun Ho ^h   Kim, Yong Man ⁱ   Kang, Soon Beom ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Cheil General Hospital   (South Korea)

^d Dongsan Medical Center   (South Korea)

^e Korea Cancer Center Hospital   (South Korea)

^f Ajou University Medical Center   (South Korea)

^g Samsung Medical Center   (South Korea)

^h The Catholic University of Korea   (South Korea)

ⁱ Asan Medical Center   (South Korea)

Author keywords

Endometrial cancer; Ovary; Preservation

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; EARLY CANCER; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RECURRENCE RISK; SOUTH KOREA; VAGINAL HYSTERECTOMY;

ADULT; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; OVARY;

EID: 69249206566     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.041     Document Type: Article

References (27)

1. Ryu H.S. Contemporary clinical trials in uterine corpus malignancies. Korean J. Obstet. Gynecol. 50 (2007) 1299-1307
2. Annual Report of Gynecologic Cancer Registry Program in Korea for 2004. Korean J. Obstet. Gynecol. 50 (2007) 28-78
3. Lee S.E., Kim J.W., Park N.H., Song Y.S., Kang S.B., and Lee H.P. Contemporary trends of endometrial cancer in Korean women. Korean J. Gynecol. Oncol. 16 (2005) 215-220
4. Ali-Fehmi R., Cote M.L., Arabi M.H., Munkarah A.R., Schimp V.L., Bryant C., et al. Endometrial carcinoma (EC) in women 35 years of age or younger ASCO Meeting Abstracts. J. Clin. Oncol. 25 (2007) 16000
5. Shimada M., Kigawa J., Nishimura R., Yamaguchi S., Kuzuya K., Nakanishi T., et al. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol. Oncol. 101 (2006) 234-237
6. Landoni F., Zanagnolo V., Lovato-Diaz L., Maneo A., Rossi R., Gadduci A., et al. Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int. J. Gynecol. Cancer 17 (2007) 623-628
7. Ramirez P.T., Schmeler K.M., Soliman P.T., and Frumovitz M. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol. Oncol. 110 3 Suppl 2 (2008) S25-28
8. Lee T.S., Jung J.Y., Kim J.W., Park N.H., Song Y.S., Kang S.B., et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol. Oncol. 104 (2007) 52-57
9. Tran B.N., Connell P.P., Waggoner S., Rotmensch J., and Mundt A.J. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am. J. Clin. Oncol. 23 (2000) 476-480
10. Kaku T., Matsuo K., Tsukamoto N., Shimamoto T., Sugihara K., Tsuruchi N., et al. Endometrial carcinoma in women aged 40 years or younger: a Japanese experience. Int. J. Gynecol. Cancer 3 (1993) 147-153
11. Duska L.R., Garrett A., Rueda B.R., Haas J., Chang Y., and Fuller A.F. Endometrial cancer in women 40 years old or younger. Gynecol. Oncol. 83 (2001) 388-393
12. Gitsch G., Hanzal E., Jensen D., and Hacker N.F. Endometrial cancer in premenopausal women 45 years and younger. Obstet. Gynecol. 85 (1995) 504-508
13. Evans-Metcalf E.R., Brooks S.E., Reale F.R., and Baker S.P. Profile of women 45 years of age and younger with endometrial cancer. Obstet. Gynecol. 91 (1998) 349-354
14. Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., and Buller R.E. Simultaneously detected endometrial and ovarian carcinomas-a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol. Oncol. 83 (2001) 355-362
15. Walsh C., Holschneider C., Hoang Y., Tieu K., Karlan B., and Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet. Gynecol. 106 (2005) 693-699
16. Han C.H., Lim S.Y., Kook I.Y., Lee K.H., Namkoong S.E., Park J.S., et al. Prognostic outcome of patients with clinical stage I-II endometrial cancer according to bilateral salpino-oophorectomy. Korean J. Obstet. Gynecol. 50 (2007) 288-294
17. Suriano K.A., McHale M., McLaren C.E., Li K.T., Re A., and DiSaia P.J. Estrogen replacement therapy in endometrial cancer patients. Obstet. Gynecol. 97 (2001) 555-560
18. Ayhan A., Taskiran C., Simsek S., and Sever A. Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?. Int. J. Gynecol. Cancer 16 (2006) 805-808
19. Tangjitgamol S., Manusirivithaya S., Hanprasertpong J., and Kavanagh J.J. Hormone replacement therapy after treatment of endometrial cancer. Gynecol. Obstet. Invest. 65 (2008) 35-38
20. Barakat R.R., Bundy B.N., Spirtos N.M., Bell J., and Mannel R.S. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 24 (2006) 587-592
21. Carlson R.W., and McCormick B. Update: NCCN breast cancer clinical practice guidelines. J. Natl. Compr. Cancer Netw. 3 Suppl 1 (2005) S7-11
22. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., and Melton III L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 7 (2006) 821-828
23. Benjamin I., Morgan M.A., and Rubin S.C. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol. Oncol. 72 (1999) 288-291
24. Israel O., Mor M., Guralnik L., Hermoni N., Gaitini D., Bar-Shalom R., et al. Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?. J. Nucl. Med. 45 (2004) 2045-2051
25. Bristow R.E., del Carmen M.G., Pannu H.K., Cohade C., Zahurak M.L., Fishman E.K., et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol. Oncol. 90 (2003) 519-528
26. Ames J., Blodgett T., and Meltzer C. 18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma. AJR Am. J. Roentgenol. 185 (2005) 1057-1059
27. Short S., Hoskin P., and Wong W. Ovulation and increased FDG uptake on PET: potential for a false-positive result. Clin. Nucl. Med. 30 (2005) 707